A Hong Kong research team, led by Dr Ma Cong (right), has developed nusbiarylins, a new class of antibiotic to help fight superbugs. Chan Shu Ting (left) is a student participating in the project. A Hong Kong research team, led by Dr Ma Cong (right), has developed nusbiarylins, a new class of antibiotic to help fight superbugs. Chan Shu Ting (left) is a student participating in the project.
A Hong Kong research team, led by Dr Ma Cong (right), has developed nusbiarylins, a new class of antibiotic to help fight superbugs. Chan Shu Ting (left) is a student participating in the project.

Wellness

Drug-resistant MRSA: Hong Kong scientists develop antibiotic that offers hope in the war against superbugs

  • Antibiotic-resistant superbugs such as MRSA are a major threat to global health, with conventional treatments failing to work
  • Experts from two Hong Kong universities have created a new drug that halts bacteria’s spread

Topic |   Wellness
A Hong Kong research team, led by Dr Ma Cong (right), has developed nusbiarylins, a new class of antibiotic to help fight superbugs. Chan Shu Ting (left) is a student participating in the project. A Hong Kong research team, led by Dr Ma Cong (right), has developed nusbiarylins, a new class of antibiotic to help fight superbugs. Chan Shu Ting (left) is a student participating in the project.
A Hong Kong research team, led by Dr Ma Cong (right), has developed nusbiarylins, a new class of antibiotic to help fight superbugs. Chan Shu Ting (left) is a student participating in the project.
READ FULL ARTICLE